Low back pain management in routine clinical practice – what is important for the individual patient? - Supplementary material

<strong>Table 1. </strong>Study characteristics and patients’ baseline data

<strong>Table 2. </strong> Mean change from baseline to end of observation in pain intensity and pain-related aspects under tapentadol PR treatment and responder rates (NIT 1-3)

<strong>Table 3. </strong>Mean change from baseline to end of observation in pain intensity and daily functioning under tapentadol PR treatment and responder rates (NIT-4)

<strong>Table 4. </strong>Mean change from baseline to end of observation in daily functioning and quality of life under tapentadol PR

<strong>Table 5. </strong>Attainment of additional individual treatment goals with tapentadol PR, jointly chosen by physician and patient

<strong>Table 6. </strong>Questionnaire used for the online patient research survey

<strong>Table 7. </strong>SF-12 domains included in the principal questionnaire used for the online patient research survey versus the original SF-12 domains

<strong>Table 8. </strong>Sociodemographic characteristics of the survey respondents (N = 300)

<strong>Figure 1. </strong>The most important goals of chronic back pain therapy (online patient research survey question 1 ‘important treatment goal’ [unprompted]).

<strong>Table 9. </strong>Online patient research survey - Importance of individual top-3 SF-12 domains and other additional aspects by age, pain intensity, and gender
<br>